Having my boyfriend who has been there through it all hood me at my UCSF School of Medicine graduation was such a special moment 😊. Happy pride month! 🏳️‍🌈 #gaysinstem #MedTwitter

Please checkout the updated version of our preprint, a result of a great collaboration with ⁦Bivona Lab @HarrisLabUMN with my mentors Charles Swanton and⁩ Julian Downward. Work done The Francis Crick Institute Swanton Lab #Downwardlab biorxiv.org/content/10.110…

What's your approach to a patient with altered mental status + involuntary movements? Learn more in this month's Clinical Care Conundrum! bit.ly/3aSpf5n Nicholas J Thomas, MD Rabih Geha Sharmin Shekarchian Meredith Bock

Modern medicine is carrying 3 iPhones in a tiny Patagonia pocket

When are we going to start putting the phonetic spelling of patient names in the chart? Seems long overdue

Thank you Dr. Brondfield for your amazing mentorship!

When you're back on cardiology at Zuckerberg General 1 yr later as a PGY2 w/ this incredibly diverse, awesome rock star team! ❤️❤️ Shout out to Dr. Chorba who encourages heart healthy exercise w/ 6 flights of stairs daily! 😅💪🏾😁 UCSF IM Chiefs #zsfg

🗣️ #OncEmergencies old and new! Nicholas J Thomas, MD & Sam Brondfield, MD, MAEd, FASCO of UCSF Health review life-threatening side effects of 🎯 targeted therapies in oncology. UCSF Helen Diller Family Comprehensive Cancer Ctr UCSFHospitalMedicine Society of Hospital Medicine ASCO bit.ly/3mx5NRt #VisualAbstract by Suchita Shah Sata, MD

Novel oncologic therapies can have life-threatening side effects 😵 Nicholas J Thomas, MD & Sam Brondfield, MD, MAEd, FASCO of UCSF Health review #OncEmergencies related to 🎯 targeted therapies. UCSF Helen Diller Family Comprehensive Cancer Ctr UCSFHospitalMedicine Society of Hospital Medicine ASCO bit.ly/3mx5NRt #VisualAbstract by Suchita Shah Sata, MD

🎉 After years of hard work, I'm SO proud to launch Synaptiq Life Pro – the most powerful medical flashcard platform ever!🩺 ‣ School-specific decks ‣ Step & Shelf decks ‣ Real-time collab ‣ Live MD support ‣ *Gorgeous* redesign ‣ AXON·AI medical tutor synaptiq.app/sign_up

Our latest paper is out now in Orli Bahcall! We investigate how APOBEC3B affects EGFR mutant non-small cell lung cancer evolution, from tumor initiation to targeted therapy resistance. nature.com/articles/s4158…

I am excited to announce the publication of our manuscript out today, with Philippe Gui, Charles Swanton, Swanton Lab, Bivona Lab, @Downwardlab, and The Harris Lab! 🧵 1/15 nature.com/articles/s4158…

Thrilled to have worked w/ The Pike Lab, Chad Rusthoven, & colleagues in this Journal of Clinical Oncology publication! 👏 ▶️ascopubs.org/doi/full/10.12… Key points listed below! Optimal use of upfront SRS for brain mets in #EGFR & #ALK pts is controversial.

Any benefit w/ upfront SRS for EGFR and ALK positive NSCLC brain Mets treated w/CNS penetrant TKI? · ↑↑LC and CNS control · No diff OS · 10% symptomatic RN after SRS ascopubs.org/doi/10.1200/JC…

Featured today by MSK Library: Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC) #NSCLC #BrainMetastases #EGFRPositive #ALKPositive #TKITherapy

We are thrilled to announce the Hematology/Oncology fellows who will be joining MSK in July 2025! We can't wait to welcome these talented trainees. Memorial Sloan Kettering Cancer Center #Match2024